FDA Approves First Therapy for Rare Pediatric Immune Disorder
The US Food and Drug Administration has approved the regenerative tissue-based therapy Rethymic for patients with congenital athymia, a rare
Read more
Preventing life-threatening pediatric condition starts with pandemic safeguards
Adults can be the first line of defense when it comes to avoiding the worst outcomes from multisystem inflammatory syndrome
Read more
Focus on Youth Concerns at Well Visits
Taking teens’ strengths, values, and dreams, into account through a previsit questionnaire was acceptable to them and may promote discussions
Read more